Vodafone Certified application status for the MedifyRemote™ application

vodafoneMedify Solutions Limited announced that it has been awarded Vodafone Certified application status for its MedifyRemote™ application. MedifyRemote™ is the first application of its type and allows healthcare professionals mobile access to review and update a patients' medical history records in a single, secure session via a standard Microsoft Windows Mobile PDA/phone device. The application offers no interference with the existing device functions, enabling one device to be utilised for telephone, email, calendar, internet access; as well patient note functions.

In order to achieve Vodafone Certified status, MedifyRemote™ underwent technical evaluation by Vodafone UK. As a result, the application has passed the approval process, meeting the high standards demanded by Vodafone UK's customer base and delivering value to the UK marketplace.

As a Certified application, Medify Solutions Limited now has access to Vodafone UK's technical expertise and will be recommended to appropriate customers by Vodafone UK account managers. MedifyRemote™ will be identified by the "Vodafone Certified Application" brand logo. This will allow Medify Solutions Limited to benefit from Vodafone UK's position as the UK's largest mobile network operator, offering its customers in-depth support and peace of mind when deploying new mobile applications.

Ian O'Reilly, CEO Medify Solutions Limited, said: "Gaining Vodafone Certified status represents a superb endorsement for the MedifyRemote™ application. Our mobile application is successfully leading the way in the UK NHS and the rapid development of the e-Healthcare sector. The recognition of the importance of MedifyRemote™ by a major organisation such as Vodafone UK, underlines the value that this application delivers to clinical users and partners alike. We are very much looking forward to continuing the strong partnership we have formed with Vodafone UK."

Nick Parbutt, Head of Enterprise Product, Vodafone UK said: "For many of our customers, mobile data applications, such as job scheduling or workforce management are a business imperative. Having experienced the business benefits that such applications deliver, these customers are now considering additional solutions to address day-to-day business requirements. Medify Solutions Limited has proven that it can address these needs and we look forward to working with its team to enable our customers to realise the efficiencies that MedifyRemote™ delivers."

MedifyRemote™ joins a number of other Certified application developers in the Vodafone UK applications portfolio which have developed solutions ranging from telematics and sales solutions to tools that replicate the functionality or content from the desktop environment on to the mobile device.

Those interested in further information should email This email address is being protected from spambots. You need JavaScript enabled to view it. or visit www.medifysolutions.com

About the Medify Solutions
The Medify Solutions group of companies are focused on the development, taking to market and delivery of leading edge mobile solutions for the healthcare market. With operations across the EU, Medify are at the forefront of the technology revolution in patient care. For more information, please visit www.medifysolutions.com.

About Vodafone UK
Vodafone UK has 16.3 million customers and is part of the world’s leading international mobile telecommunications Group, offering a wide range of voice and data communications. The company is committed to providing mobile solutions that allow both consumer and business customers to make the most of now. In addition, Vodafone connects customers across the globe with roaming agreements worldwide. It provides 3G roaming in 29 countries and offers great roaming value with Vodafone Passport. For more information, please visit www.vodafone.co.uk.

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...